Author

Udo Hoffmann

Professor of Radiology, Harvard University, Massachusetts General Hospital - Cited by 1,13,335

Biography

Dr. Hoffmann received his medical degree and doctorate from the University of Leipzig, Germany in 1995, followed by an internship in the Division of Cardiology and radiology residency at the General Hospital and University of Vienna, Austria. In 2001, Dr. Hoffmann joined the MGH Department of Radiology. After a two year fellowship in cardiovascular imaging, Dr. Hoffmann became a clinical faculty and was appointed Instructor in Radiology at Harvard Medical School in 2003. He subsequently was promoted to Assistant Professor in 2004, to Associate Professor in 2007, and to Professor in 2013.
Title
Cited by
Year
Deep learning enables genetic analysis of the human thoracic aorta
JP Pirruccello, MD Chaffin, EL Chou, SJ Fleming, H Lin, M Nekoui, ...Nature genetics 54 (1), 40-51, 2022202
71
2022
Deep learning to estimate biological age from chest radiographs
VK Raghu, J Weiss, U Hoffmann, HJWL Aerts, MT LuCardiovascular Imaging 14 (11), 2226-2236, 2021202
29
2021
Genetic analysis of right heart structure and function in 40,000 people
JP Pirruccello, P Di Achille, V Nauffal, M Nekoui, SF Friedman, ...Nature genetics 54 (6), 792-803, 222
20
2022
Cardiovascular risk and health among people with human immunodeficiency virus (HIV) eligible for primary prevention: insights from the REPRIEVE trial
PS Douglas, T Umbleja, GS Bloomfield, CJ Fichtenbaum, MV Zanni, ...Clinical Infectious Diseases 73 (11), 2009-2022, 2021202
17
2021
Statin use, heart radiation dose, and survival in locally advanced lung cancer
KM Atkins, DS Bitterman, TL Chaunzwa, CL Williams, R Rahman, ...Practical Radiation Oncology 11 (5), e459-e467, 2021202
16
2021
Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 years: the Framingham Heart Study
WY Park, I Yiannakou, JM Petersen, U Hoffmann, J Ma, MT LongClinical Gastroenterology and Hepatology 20 (11), 2524-2532. e2, 2022202
14
2022
Risk stratification with the use of coronary computed tomographic angiography in patients with nonobstructive coronary artery disease
J Taron, B Foldyna, T Mayrhofer, MT Osborne, N Meyersohn, DO Bittner, ...Cardiovascular Imaging 14 (11), 2186-2195, 2021202
13
2021
Elevated coronary artery calcium quantified by a validated deep learning model from lung cancer radiotherapy planning scans predicts mortality
KM Atkins, J Weiss, R Zeleznik, DS Bitterman, TL Chaunzwa, E Huynh, ...JCO clinical cancer informatics 6, e2100095, 2022202
7
2022
Matrix Gla protein levels are associated with arterial stiffness and incident heart failure with preserved ejection fraction
R Malhotra, CJ Nicholson, D Wang, V Bhambhani, S Paniagua, C Slocum, ...Arteriosclerosis, Thrombosis, and Vascular Biology 42 (2), e61-e3, 2022202
7
2022
Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose …
MC Tjong, DS Bitterman, K Brantley, A Nohria, U Hoffmann, KM Atkins, ...Radiotherapy and Oncology 169, 105-113, 2022202
7
2022
Coronary atherosclerosis, cardiac troponin, and interleukin-6 in patients with chest pain: The PROMISE trial results
M Ferencik, T Mayrhofer, MT Lu, DO Bittner, H Emami, SB Puchner, ...Cardiovascular Imaging 15 (8), 142-1438, 2022202
7
2022
Association of cardiometabolic disease with cancer in the community
EE Liu, N Suthahar, SM Paniagua, D Wang, ES Lau, SX Li, M Jovani, ...Cardio Oncology 4 (1), 9-81, 2022202
6
2022
Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial
M Kolossváry, T Mayrhofer, M Ferencik, J Karády, NJ Pagidipati, SH Shah, ...Journal of Cardiovascular Computed Tomography 1 (5), 397-403, 2022202
6
2022
Quality and safety of coronary computed tomography angiography at academic and non-academic sites: insights from a large European registry (ESCR MR/CT Registry)
B Foldyna, J Uhlig, R Gohmann, C Lücke, T Mayrhofer, L Lehmkuhl, ...European Radiology 32 (8), 524-5255, 2022202
6
2022
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation …
MP Bonaca, DA Morrow, BA Bergmark, DD Berg, JAC Lima, U Hoffmann, ...Circulation 146 (12), 907-916, 2022202
5
2022
Radiologists can visually predict mortality risk based on the gestalt of chest radiographs comparable to a deep learning network
J Weiss, J Taron, Z Jin, T Mayrhofer, HJWL Aerts, MT Lu, U HoffmannScientific reports 11 (1), 1986, 2021202
5
2021
Coronary calcium scoring improves risk prediction in patients with suspected obstructive coronary artery disease
S Winther, SE Schmidt, B Foldyna, T Mayrhofer, LD Rasmussen, JN Dahl, ...Journal of the American College of Cardiology 80 (21), 196-1977, 2022202
5
2022
Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy
C Lee, ZD Drobni, A Zafar, CA Gongora, DA Zlotoff, RM Alvi, J Taron, ...Cardio Oncology 4 (), 660-669, 2022202
5
2022
The PROMISE minimal risk score improves risk classification of symptomatic patients with suspected CAD
LD Rasmussen, CB Fordyce, L Nissen, CL Hill Jr, B Alhanti, U Hoffmann, ...Cardiovascular Imaging 15 (8), 12-15, 2022202
4
2022
Deep learning analysis of chest radiographs to triage patients with acute chest pain syndrome
M Kolossváry, VK Raghu, JT Nagurney, U Hoffmann, MT LuRadiology 306 (2), e221926, 2023202
4
2023

Referred From: https://scholar.google.com/citations?user=g5vfMTsAAAAJ&hl=en

Cited by
Citations 113335
h-index 122
i10-index 590
Recommended Journals
Open Access Journals